Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Pharma shares witnessed buying interest for six consecutive trading session.
At 11:25 IST, the barometer index, the S&P BSE Sensex declined 107.51 points or 0.13% to 80,891.89. The Nifty 50 index shed 41.45 points or 0.17% to 24,944.95.
In the broader market, the BSE 150 MidCap Index declined 0.33% and the BSE 250 SmallCap Index fell 0.37%.
The market breadth was negative. On the BSE, 1,678 shares rose and 2,352 shares fell. A total of 275 shares were unchanged.
Buzzing Index:
The Nifty Pharma Index jumped 1.78% to 28,933.45. The index jumped 6.75% in the six consecutive trading sessions.
Gland Pharma (up 6.62%), Sai Life Sciences (up 5.64%), Divis Laboratories (up 5%), Laurus Labs (up 4.33%), Glenmark Pharmaceuticals (up 3.49%), Wockhardt (up 2.93%), Mankind Pharma (up 2.92%), Alkem Laboratories (up 2.69%), Zydus Lifesciences (up 2.55%) and Aurobindo Pharma (up 1.86%) surged.
Global Market:
Dow futures rose 362 points, signalling a strong opening for US stocks.
Most Asian indices traded higher on Monday, 9 November 2026, as investors assessed the latest US market rebound, fresh economic data and the outlook for interest rates. Trading remained cautious following last week's sharp volatility in technology and semiconductor stocks. Investors also monitored developments in US-China trade relations and movements in crude oil prices.
China's inflation data released on Monday showed producer prices rising 5.7% year-on-year in October, accelerating from 5% in September. Consumer inflation slowed to 0.7% from 0.9%, while core inflation eased to 0.8% from 1%.
The data pointed to persistent cost pressures at the producer level, while subdued consumer demand continued to limit broader price increases.
US stocks ended mixed on Friday, 06 November 2026, as technology shares recovered from the previous session's sharp sell-off. The S&P 500 rose 0.31% to 7,376.86, while the Nasdaq Composite advanced 1.09% to 24,579.42. The Dow Jones Industrial Average declined 0.46% to 51,285.73.
Semiconductor and AI-related stocks led Friday's recovery. Advanced Micro Devices (AMD) surged around 11%, while Nvidia gained 2.8% and Micron Technology advanced 5.1%. Intel also climbed 7.7% as investors bought beaten-down technology stocks. IREN jumped 20% following stronger-than-expected revenue and growth in its AI cloud business.
Airbnb gained 11.7% after reporting stronger third-quarter demand and raising its full-year revenue growth outlook to the high teens. The company also lifted its adjusted EBITDA margin forecast to around 36%.
The US labour market delivered a stronger-than-expected performance in October. Non-farm payrolls increased by 165,000, against expectations of around 65,000. September's job additions were revised upwards to 60,000 from 29,000. The unemployment rate declined to 4.1% from 4.2%.
Average hourly earnings rose 0.4% month-on-month and 3.1% year-on-year. The stronger employment data reinforced expectations that the Federal Reserve could raise interest rates in December. Market-implied odds of a 25-basis-point increase rose to around 79%, compared with 71% a week earlier.
The next major US data release is the October consumer price index (CPI), scheduled for Tuesday, 10 November 2026. The reading will be important in assessing whether inflationary pressures could prompt further monetary tightening.
Brent crude futures declined in early Monday trading followed by comments from US President Donald Trump that fresh attacks on Iran were unlikely if negotiations to end the conflict continued.
Brent had fallen 17% last week, marking its steepest weekly decline since the start of the Covid-19 pandemic. However, reports of attacks on vessels near the Strait of Hormuz kept geopolitical risks in focus. Iraq also reached an understanding with the US to allow oil exports through the strait using a shipping lane near Oman.
Revenue from operations increased 22.7% YoY to Rs 659 crore in Q2 FY27 from Rs 537 crore in Q2 FY26. On a sequential basis, revenue rose 19.0% from Rs 554 crore in Q1 FY27.
EBITDA rose 19.9% YoY to Rs 187 crore from Rs 156 crore. Sequentially, EBITDA increased 26.4% from Rs 148 crore.
EBITDA margin stood at 28% against 29% in the year-ago quarter and 27% in Q1 FY27.
Profit before tax rose 17.0% YoY to Rs 131 crore from Rs 112 crore. It increased 33.7% QoQ from Rs 98 crore in Q1 FY27.
Total expenses increased 20.5% YoY to Rs 531.27 crore in Q2 FY27. Cost of materials, chemicals and reagents consumed rose 17.1% YoY to Rs 170.07 crore from Rs 145.18 crore. Employee benefits expense increased 21.7% YoY to Rs 198.06 crore from Rs 162.79 crore. Finance costs rose 17.0% to Rs 10.94 crore, while depreciation and amortisation increased 21.1% to Rs 48.13 crore.
The company's CDMO business contributed 64% of revenue, while CRO accounted for the remaining 36%. Capacity utilisation stood at 67% in Q2 FY27.
The company incurred capital expenditure of Rs 621 crore during H1 FY27, including Rs 358 crore in Q2. It remains on track to achieve its overall capex projection of Rs 1,100-1,300 crore.
Managing Director and CEO Krishna Kanumuri said Q2 FY27 was a strong quarter, supported by continued business momentum and progress across key strategic priorities. He highlighted growing traction with global pharmaceutical companies, increased adoption of the integrated outsourcing model and the expansion of capacity and capabilities.
Chief Financial Officer Siva Chittor said the performance was broad-based, with both CRO and CDMO businesses delivering healthy growth. He added that the company expects a stronger second half, supported by the progression of its development and commercial pipeline and the ramp-up of new capacity.
Sai Life Sciences is a Hyderabad-based Contract Research, Development and Manufacturing Organization (CRDMO) that provides drug discovery, development and manufacturing services to pharmaceutical and biotechnology companies. Its operations span process development, clinical and commercial manufacturing, and advanced technology platforms, with a global customer base.
Sai Life Sciences Ltd, Alembic Pharmaceuticals Ltd, SML Mahindra Ltd and Glenmark Pharmaceuticals Ltd are among the other gainers in the BSE's 'A' group today, 06 November 2026.
Tata Teleservices (Maharashtra) Ltd surged 14.34% to Rs 40.5 at 11:44 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 45.24 lakh shares were traded on the counter so far as against the average daily volumes of 17 lakh shares in the past one month.
Sai Life Sciences Ltd spiked 10.39% to Rs 1762. The stock was the second biggest gainer in 'A' group. On the BSE, 5.42 lakh shares were traded on the counter so far as against the average daily volumes of 57319 shares in the past one month.
Alembic Pharmaceuticals Ltd soared 7.31% to Rs 961.2. The stock was the third biggest gainer in 'A' group. On the BSE, 89603 shares were traded on the counter so far as against the average daily volumes of 41744 shares in the past one month.
SML Mahindra Ltd added 5.00% to Rs 5262. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2740 shares were traded on the counter so far as against the average daily volumes of 4468 shares in the past one month.
Glenmark Pharmaceuticals Ltd jumped 4.86% to Rs 2606.4. The stock was the fifth biggest gainer in 'A' group. On the BSE, 99678 shares were traded on the counter so far as against the average daily volumes of 20422 shares in the past one month.
Billionbrains Garage Ventures Ltd, Sai Life Sciences Ltd, Astral Ltd, Aptus Value Housing Finance India Ltd are among the other stocks to see a surge in volumes on BSE today, 06 November 2026.
Lenskart Solutions Ltd notched up volume of 274.22 lakh shares by 10:44 IST on BSE, a 43.46 fold spurt over two-week average daily volume of 6.31 lakh shares. The stock rose 0.93% to Rs.725.05. Volumes stood at 16.38 lakh shares in the last session.
Billionbrains Garage Ventures Ltd saw volume of 1106.94 lakh shares by 10:44 IST on BSE, a 29.98 fold spurt over two-week average daily volume of 36.93 lakh shares. The stock dropped 5.12% to Rs.212.20. Volumes stood at 32.67 lakh shares in the last session.
Sai Life Sciences Ltd registered volume of 3.93 lakh shares by 10:44 IST on BSE, a 15.52 fold spurt over two-week average daily volume of 25335 shares. The stock rose 10.98% to Rs.1,771.45. Volumes stood at 45344 shares in the last session.
Astral Ltd registered volume of 2.9 lakh shares by 10:44 IST on BSE, a 14.12 fold spurt over two-week average daily volume of 20545 shares. The stock slipped 10.92% to Rs.1,234.90. Volumes stood at 26606 shares in the last session.
Aptus Value Housing Finance India Ltd saw volume of 36.79 lakh shares by 10:44 IST on BSE, a 12.31 fold spurt over two-week average daily volume of 2.99 lakh shares. The stock dropped 2.22% to Rs.176.20. Volumes stood at 14.57 lakh shares in the last session.
Sai Life Sciences Ltd, Thermax Ltd, Vardhman Textiles Ltd, Astral Ltd are among the other stocks to see a surge in volumes on NSE today, 06 November 2026.
JSW Cement Ltd notched up volume of 356.43 lakh shares by 14:09 IST on NSE, a 26.19 fold spurt over two-week average daily volume of 13.61 lakh shares. The stock slipped 1.42% to Rs.120.78. Volumes stood at 8.82 lakh shares in the last session.
Sai Life Sciences Ltd recorded volume of 97.12 lakh shares by 14:09 IST on NSE, a 20.17 times surge over two-week average daily volume of 4.82 lakh shares. The stock gained 13.39% to Rs.1,808.00. Volumes stood at 5.47 lakh shares in the last session.
Thermax Ltd saw volume of 23.18 lakh shares by 14:09 IST on NSE, a 15.85 fold spurt over two-week average daily volume of 1.46 lakh shares. The stock dropped 17.91% to Rs.2,725.10. Volumes stood at 2.69 lakh shares in the last session.
Vardhman Textiles Ltd registered volume of 18.38 lakh shares by 14:09 IST on NSE, a 10.93 fold spurt over two-week average daily volume of 1.68 lakh shares. The stock slipped 5.57% to Rs.505.15. Volumes stood at 2.84 lakh shares in the last session.
Astral Ltd registered volume of 41.6 lakh shares by 14:09 IST on NSE, a 10.49 fold spurt over two-week average daily volume of 3.97 lakh shares. The stock slipped 9.88% to Rs.1,250.90. Volumes stood at 4.94 lakh shares in the last session.
Sai Life Sciences Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1549.8, up 3.62% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 23102.8. The Sensex is at 74685.25, up 0.72%. Sai Life Sciences Ltd has risen around 0.56% in last one month.
Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has risen around 3.43% in last one month and is currently quoting at 26710.8, up 1.88% on the day. The volume in the stock stood at 7.68 lakh shares today, compared to the daily average of 4.37 lakh shares in last one month.
The PE of the stock is 88.15 based on TTM earnings ending June 26.
Sai Life Sciences Ltd rose for a third straight session today. The stock is quoting at Rs 1617, up 1.03% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.29% on the day, quoting at 23413.6. The Sensex is at 74819.64, up 0.71%. Sai Life Sciences Ltd has added around 12.61% in last one month.
Meanwhile, Nifty Pharma index of which Sai Life Sciences Ltd is a constituent, has added around 2.67% in last one month and is currently quoting at 26710.1, up 1.25% on the day. The volume in the stock stood at 2.26 lakh shares today, compared to the daily average of 9.32 lakh shares in last one month.
The PE of the stock is 94.34 based on TTM earnings ending June 26.